|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4,025 KRW | -1.11% |
|
-2.54% | +3.07% |
GenoFocus, Inc. reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was KRW 55.04 million compared to KRW 14.55 million a year ago. Net loss was KRW 3,063.82 million compared to KRW 2,325.79 million a year ago.
Basic loss per share from continuing operations was KRW 136 compared to KRW 103 a year ago. Basic loss per share was KRW 136 compared to KRW 103 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +3.07% | 67.7M | |
| +5.41% | 106B | |
| -4.31% | 64.74B | |
| +73.33% | 49.34B | |
| +17.24% | 39.15B | |
| +6.13% | 32.86B | |
| +12.77% | 20.29B | |
| +15.03% | 17.21B | |
| +19.06% | 15.28B | |
| +6.28% | 14.58B |
GENOFOCUS, INC. 
